SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from Apyx Medical (APYX) — May 16, 2018

Apyx Medical Corp
Date: May 16, 2018 · CIK: 0000719135 · Accession: 0000719135-18-000037

AI Filing Summary & Sentiment

File numbers found in text: 333-224677

Date
May 16, 2018
Author
BOVIE MEDICAL CORPORATION
Form
CORRESP
Company
Apyx Medical Corp

Letter

Re:

Document

May 16, 2018

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F. St., N.E.

Washington, D.C. 20549

Request for Acceleration of Effectiveness of Registration Statement on Form S-3 (File No. 333-224677) of Bovie Medical Corporation (the “Registrant”)

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, and on behalf of the Registrant, we hereby request that the effectiveness of the above-captioned Registration Statement (the “Registration Statement”) be accelerated so that such Registration Statement will become effective on Wednesday, May 16, 2018 at 4:00 p.m., Eastern Time, or as soon thereafter as practicable.

The Registrant hereby authorizes Adam P. Silvers, of Ruskin Moscou Faltischek, P.C., to orally modify or withdraw this request for acceleration.

We request that we be notified of such effectiveness by a telephone call to Mr. Silvers at (516) 663-6519, or in his absence Michael S. Williams, of Ruskin Moscou Faltischek, P.C., at (516) 663-6657. We also respectfully request that a copy of the written order from the Commission verifying the effective time and date of such Registration Statement be sent to Ruskin Moscou Faltischek, P.C., attention: Adam P. Silvers, via email at asilvers@rmfpc.com.

Very truly yours,
BOVIE MEDICAL CORPORATION

Show Raw Text
CORRESP
1
filename1.htm

		Document

CORRESP

May 16, 2018

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F. St., N.E.

Washington, D.C. 20549

 Re:

 Request for Acceleration of Effectiveness of Registration Statement on Form S-3 (File No.  333-224677) of Bovie Medical Corporation (the “Registrant”)

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, and on behalf of the Registrant, we hereby request that the effectiveness of the above-captioned Registration Statement (the “Registration Statement”) be accelerated so that such Registration Statement will become effective on Wednesday, May 16, 2018 at 4:00 p.m., Eastern Time, or as soon thereafter as practicable.

The Registrant hereby authorizes Adam P. Silvers, of Ruskin Moscou Faltischek, P.C., to orally modify or withdraw this request for acceleration.

We request that we be notified of such effectiveness by a telephone call to Mr. Silvers at (516) 663-6519, or in his absence Michael S. Williams, of Ruskin Moscou Faltischek, P.C., at (516) 663-6657. We also respectfully request that a copy of the written order from the Commission verifying the effective time and date of such Registration Statement be sent to Ruskin Moscou Faltischek, P.C., attention: Adam P. Silvers, via email at asilvers@rmfpc.com.

 Very truly yours,

BOVIE MEDICAL CORPORATION

 By:

 /s/ JAY D. EWERS

 Name:

Title:

 Jay D. Ewers

Chief Financial Officer

763495